CPT code 17273 covers non-excisional destruction of a malignant skin lesion measuring 2.1 cm to 3.0 cm in diameter located on anatomically sensitive sites including the scalp, neck, hands, feet, or genitalia. This procedure-level code is important nationally because it captures care for malignant cutaneous lesions treated with ablative techniques such as chemosurgery, cryosurgery, or electrosurgery — procedures that have implications for outpatient surgical workflow, coding accuracy, and reimbursement for dermatology and surgical specialties.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the clinical context for lesion destruction procedures, common sites of service, and the service type represented by the code. The publication summarizes benchmarks and payer coverage patterns where available, highlights policy and coding considerations relevant to non-excisional destructive techniques, and outlines the types of documentation and clinical details typically associated with billing this code. Data not available in the input is noted where applicable.